| Business Name: |
Pharmacon Nuclear Inc |
| Contact Person: |
Claude Tatro |
| Address: |
3812 Mcelroy Road, Atlanta, Georgia 30340 |
| Phone Number: |
(678) 209-0409 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
1976 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Operators of Nonresidential Buildings |
| SIC Code: |
6512 |
| NAICS Code: |
531312 |
| Share This Business: |
|
| Related Businesses: |
Maxim Properties Inc - Atlanta, GA 30340
Private Properties LLC - Atlanta, GA 30340
Mpg Ventures LLC - Atlanta, GA 30340
Cmy Property LLC - Atlanta, GA 30340
Troung & Le Properties LLC - Atlanta, GA 30340
Jinix Inc - Atlanta, GA 30340
Davidson Properties - Atlanta, GA 30340
Avj Properties LLC - Atlanta, GA 30340
Segrest Properties LLC - Atlanta, GA 30340
4095 Properties LLC - Atlanta, GA 30340
Golden Parkway Properties LLC - Atlanta, GA 30340
Cwc Properties - Atlanta, GA 30340
Cobalt Properties - Atlanta, GA 30340
Morceau Properties LLC - Atlanta, GA 30340
Kolli Properties LLC - Atlanta, GA 30340
Ga Birddog Properties - Atlanta, GA 30340
Halpern Enterprises - Atlanta, GA 30340
Bagley Properties Inc - Atlanta, GA 30340
Habit Properties Incorporated - Atlanta, GA 30340
D H S Leasing - Atlanta, GA 30340
|
The company Pharmacon Nuclear Inc provides B2B services in the form of Operators of Nonresidential Buildings from its single location in Georgia.
1 to 4 employees work for Pharmacon Nuclear Inc, and the business now earns $100.000 to $499.999 per annum.
Pharmacon Nuclear Inc was launched in 1976 and is classified under SIC code and category 6512 , and NAICS number and grouping 531312 .
To contact Pharmacon Nuclear Inc, please call Claude Tatro with the phone number (678) 209-0409 or visit its single location at 3812 Mcelroy Road in Atlanta, Georgia 30340.
The location of the single location can also be found using the coordinates 33.90317,-84.265831.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.